Bank Of America Corp Stoke Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.43 Trillion
Q3 2025

A detailed history of Bank Of America Corp transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 249,451 shares of STOK stock, worth $6.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

249,451

Previous 548,090 54.49%

Holding current value

$6.61 Million

Previous $6.22 Million 5.76%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$11.48 - $24.73 $3.43 Million - $7.39 Million	-298,639 Reduced 54.49%	249,451 $5.86 Million
Q2 2025 Aug 14, 2025	BUY	$5.9 - $11.84 $89,715 - $180,039	15,206 Added 2.85%	548,090 $6.22 Million
Q1 2025 May 15, 2025	BUY	$6.65 - $12.74 $3.48 Million - $6.67 Million	523,793 Added 5761.67%	532,884 $3.54 Million
Q4 2024 Feb 14, 2025	SELL	$10.8 - $13.92 $1.25 Million - $1.61 Million	-115,557 Reduced 92.71%	9,091 $100,000
Q3 2024 Nov 14, 2024	BUY	$12.24 - $15.92 $328,644 - $427,452	26,850 Added 27.45%	124,648 $1.53 Million

Q2 2024 Aug 14, 2024	BUY	$11.03 - $17.52 $763,176 - $1.21 Million	69,191 Added 241.87%	97,798 $1.32 Million
Q1 2024 May 15, 2024	SELL	$4.12 - $14.17 $192,535 - $662,192	-46,732 Reduced 62.03%	28,607 $386,000
Q4 2023 Feb 14, 2024	BUY	$3.37 - $5.4 $185,323 - $296,956	54,992 Added 270.27%	75,339 $396,000
Q2 2023 Aug 14, 2023	SELL	$7.93 - $13.82 $41,117 - $71,656	-5,185 Reduced 20.31%	20,347 $216,000
Q1 2023 May 12, 2023	BUY	$7.65 - $10.38 $3,978 - $5,397	520 Added 2.08%	25,532 $212,000
Q4 2022 Feb 10, 2023	BUY	$7.07 - $15.69 $135,468 - $300,636	19,161 Added 327.48%	25,012 $230,000
Q3 2022 Nov 14, 2022	SELL	$12.56 - $22.53 $131,515 - $235,911	-10,471 Reduced 64.15%	5,851 $75,000
Q2 2022 Aug 12, 2022	BUY	$10.36 - $23.93 $79,668 - $184,021	7,690 Added 89.09%	16,322 $215,000
Q1 2022 May 16, 2022	SELL	$17.19 - $26.1 $775,440 - $1.18 Million	-45,110 Reduced 83.94%	8,632 $182,000
Q4 2021 Feb 08, 2022	BUY	$18.11 - $30.72 $821,197 - $1.39 Million	45,345 Added 540.01%	53,742 $1.29 Million
Q3 2021 Nov 15, 2021	SELL	$23.65 - $34.44 $92,849 - $135,211	-3,926 Reduced 31.86%	8,397 $214,000
Q2 2021 Sep 13, 2021	BUY	$30.53 - $41.09 $376,221 - $506,352	12,323 New	12,323 $415,000

Others Institutions Holding STOK

# of Institutions

160

Shares Held

60.2M

Call Options Held

563K

Put Options Held

101K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $1.05B
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Stoke Therapeutics, Inc. Transaction History